Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eye injection aims to slow vision loss in japanese patients

NCT ID NCT06970665

First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 35 times

Summary

This study tests the safety of a monthly eye injection called ASP3021 in 20 Japanese adults aged 40 and older who have geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. Participants will receive 12 monthly injections into the affected eye and be monitored for side effects over about one year. The goal is to see if the treatment is safe and well-tolerated.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fukushima Medical University Hospital

    RECRUITING

    Fukushima, Fukushima, Japan

  • Jichi Medical University Hospital

    RECRUITING

    Shimotsuke-shi, Tochigi, Japan

  • Kagawa University Hospital

    RECRUITING

    Kita-gun, Kagawa-ken, Japan

  • Kansai Medical University Hospital

    RECRUITING

    Hirakata-shi, Osaka, Japan

  • Kyoto University Hospital

    RECRUITING

    Kyoto, Kyoto, Japan

  • Mie University Hospital

    RECRUITING

    Tsu, Mie-ken, Japan

  • Nagasaki University Hospital

    RECRUITING

    Nagasaki, Nagasaki, Japan

  • Nagoya City University Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Nihon University Hospital

    RECRUITING

    Chiyoda-ku, Tokyo, Japan

  • Seirei Hamamatsu General Hospital

    RECRUITING

    Hamamatsu, Shizuoka, Japan

  • The University of Osaka Hospital

    RECRUITING

    Suita-shi, Osaka, Japan

  • Tokyo Women's Medical University Hospital

    RECRUITING

    Shinjuku-ku, Tokyo, Japan

  • Toyama University Hospital

    RECRUITING

    Toyama, Toyama, Japan

  • University Of Yamanashi Hospital

    RECRUITING

    Chuo-shi, Yamanashi, Japan

  • University of the Ryukyus hospital

    RECRUITING

    Ginowan-shi, Okinawa, Japan

  • Yokohama City University Medical Center

    RECRUITING

    Yokohama, Kanagawa, Japan

Conditions

The condition(s) this trial relates to.

dry age related macular degeneration Geographic Atrophy macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.